跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 40,886 条关于
“Invivoscribe Inc.”
全部
40,886
临床试验
11,201
药物
1,598
机构
6,168
资讯
21,919
去年
CERo Therapeutics Advances Novel CER-T Cell Therapy for AML with Invivoscribe Diagnostic Support
3个月前
Oncology Companion Diagnostic Market to Reach USD 14.65 Billion by 2035, Driven by Precision Oncology Expansion
5个月前
Invivoscribe Achieves IVDR Class C Certification for B-Cell Lymphoma Diagnostic Assay in Europe
去年
Invivoscribe's LeukoStrat CDx FLT3 Mutation Assay Receives Regulatory Approval in UK and Switzerland
去年
Invivoscribe's LabPMM Secures New York State Approval for Ultra-Sensitive FLT3 ITD MRD Assay in AML
去年
Virios Therapeutics and Wex Pharmaceuticals Merge to Form Dogwood Therapeutics, Advancing Novel Pain and Viral Therapies
去年
LYMPHIR and Pembrolizumab Combination Shows Promise in Recurrent Solid Tumors
去年
Alnylam Pharmaceuticals Inc (ALNY) Q3 2024 Earnings Highlights
去年
IDEAYA Biosciences, Inc. (IDYA) BCG Matrix Analysis 2024
2年前
Immix Biopharma's NXC-201 Shows Promise as Outpatient CAR-T Therapy in Amyloidosis and Multiple Myeloma
第 1 页,共 2192 页
上一页
下一页